These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 2398276

  • 21. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O, Chill J, Sharon M, Kessler N, Mester B, Zolla-Pazner S, Anglister J.
    Biochemistry; 2005 May 17; 44(19):7250-8. PubMed ID: 15882063
    [Abstract] [Full Text] [Related]

  • 22. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
    Posner MR, Hideshima T, Cannon T, Mukherjee M, Mayer KH, Byrn RA.
    J Immunol; 1991 Jun 15; 146(12):4325-32. PubMed ID: 1710248
    [Abstract] [Full Text] [Related]

  • 23. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
    Cornelissen JJ, Maassen K, van Emst L, Weers PM, Harmsen M, Benaissa-Trouw BJ, Oosterlaken TA, Kraaijeveld CA, Verhoef J.
    Immunology; 1993 Aug 15; 79(4):673-80. PubMed ID: 8406595
    [Abstract] [Full Text] [Related]

  • 24. Characterization of syngeneic rat monoclonal antibodies to the HSN tumor using syngeneic monoclonal anti-idiotopic antibodies.
    Léger O, Dean CJ.
    J Immunol; 1991 Apr 15; 146(8):2879-86. PubMed ID: 1901889
    [Abstract] [Full Text] [Related]

  • 25. A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization.
    Healey DG, Dianda L, Buck D, Schroeder K, Truneh A, Sattentau QJ, Beverley PC.
    Eur J Immunol; 1991 Jun 15; 21(6):1491-8. PubMed ID: 1710569
    [Abstract] [Full Text] [Related]

  • 26. Production of a human anti-CD4 monoclonal antibody with antiidiotype to anti-HIV type 1 glycoprotein 120.
    Karpatkin S, Nardi MA, Liu LX, Kouri YH, Borkowsky W.
    AIDS Res Hum Retroviruses; 1995 Apr 15; 11(4):509-15. PubMed ID: 7632465
    [Abstract] [Full Text] [Related]

  • 27. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3).
    Bhattacharya-Chatterjee M, Chatterjee SK, Vasile S, Seon BK, Kohler H.
    J Immunol; 1988 Aug 15; 141(4):1398-403. PubMed ID: 2899603
    [Abstract] [Full Text] [Related]

  • 28. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
    Gorny MK, Xu JY, Karwowska S, Buchbinder A, Zolla-Pazner S.
    J Immunol; 1993 Jan 15; 150(2):635-43. PubMed ID: 7678279
    [Abstract] [Full Text] [Related]

  • 29. Generation of anti-idiotypic and anti-anti-idiotypic monoclonal antibodies in the same fusion. Support of Jerne's Network Theory.
    Hébert J, Bernier D, Boutin Y, Jobin M, Mourad W.
    J Immunol; 1990 Jun 01; 144(11):4256-61. PubMed ID: 2341720
    [Abstract] [Full Text] [Related]

  • 30. Angiotensin II (AII)-related idiotypic network. II. Heterogeneity and fine specificity of AII internal images analyzed with monoclonal antibodies.
    Budisavljevic M, Geniteau-Legendre M, Baudouin B, Pontillon F, Verroust PJ, Ronco PM.
    J Immunol; 1988 May 01; 140(9):3059-65. PubMed ID: 2452197
    [Abstract] [Full Text] [Related]

  • 31. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
    Laman JD, Schellekens MM, Abacioglu YH, Lewis GK, Tersmette M, Fouchier RA, Langedijk JP, Claassen E, Boersma WJ.
    J Virol; 1992 Mar 01; 66(3):1823-31. PubMed ID: 1637373
    [Abstract] [Full Text] [Related]

  • 32. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S, Julien JP, Isenman DE, Kunert R, Katinger H, Pai EF.
    J Mol Biol; 2008 Oct 17; 382(4):910-9. PubMed ID: 18692506
    [Abstract] [Full Text] [Related]

  • 33. Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.
    Cavacini LA, Emes CL, Power J, Duval M, Posner MR.
    J Immunol; 1994 Mar 01; 152(5):2538-45. PubMed ID: 7510748
    [Abstract] [Full Text] [Related]

  • 34. Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.
    Chakraborty M, Mukerjee S, Foon KA, Köhler H, Ceriani RL, Bhattacharya-Chatterjee M.
    Cancer Res; 1995 Apr 01; 55(7):1525-30. PubMed ID: 7533665
    [Abstract] [Full Text] [Related]

  • 35. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
    Palker TJ, Clark ME, Langlois AJ, Matthews TJ, Weinhold KJ, Randall RR, Bolognesi DP, Haynes BF.
    Proc Natl Acad Sci U S A; 1988 Mar 01; 85(6):1932-6. PubMed ID: 2450351
    [Abstract] [Full Text] [Related]

  • 36. Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies.
    Lopalco L, Longhi R, Ciccomascolo F, De Rossi A, Pelagi M, Andronico F, Moore JP, Schulz T, Beretta A, Siccardi AG.
    AIDS Res Hum Retroviruses; 1993 Jan 01; 9(1):33-9. PubMed ID: 7678970
    [Abstract] [Full Text] [Related]

  • 37. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S.
    J Pept Sci; 1995 Jan 01; 1(2):109-23. PubMed ID: 9222988
    [Abstract] [Full Text] [Related]

  • 38. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF, Green TD, Ross TM.
    Virology; 2004 Oct 25; 328(2):292-300. PubMed ID: 15464849
    [Abstract] [Full Text] [Related]

  • 39. Synthetic peptides from a conserved region of gp120 induce broadly reactive anti-HIV responses.
    Morrow WJ, Williams WM, Whalley AS, Ryskamp T, Newman R, Kang CY, Chamat S, Köhler H, Kieber-Emmons T.
    Immunology; 1992 Apr 25; 75(4):557-64. PubMed ID: 1592430
    [Abstract] [Full Text] [Related]

  • 40. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD, Schellekens MM, Lewis GK, Moore JP, Matthews TJ, Langedijk JP, Meloen RH, Boersma WJ, Claassen E.
    AIDS Res Hum Retroviruses; 1993 Jul 25; 9(7):605-12. PubMed ID: 8369165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.